Skip to main content

Table 1 Baseline characteristics of the simulation cohort

From: Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective

Characteristic

Value

SD

Data Source

Demographics

   

Proportion male (%)

66.1

--

PROactive

Mean age (years)

61.8

7.7

PROactive

Duration of diabetes (years)

10

7

PROactive

Ethnic Group

   

   Proportion White (%)

98.6

--

PROactive

   Proportion Black (%)

1.4

--

PROactive

Baseline risk factors

   

HbA1c (%-points)

8.1

1.4

PROactive

Systolic blood pressure (mmHg)

143.4

17.8

PROactive

BMI (kg.m-2)

30.9

4.8

PROactive

HDL-C (mmol/l)

1.2

0.3

PROactive

LDL-C (mmol/l)

3.0

1.0

PROactive

Total cholesterol (mmol/l)

2.3

0.9

PROactive

Triglycerides (mmol/l)

2.2

1.8

PROactive

Proportion smokers (%)

13.8

--

PROactive

Baseline complications

   

ACS (%)

13.65

--

PROactive

CABG/PCI (%)

30.75

--

PROactive

PVD (%)

24.3

--

PROactive

MI (%)

47.0

--

PROactive

Stroke (%)

19.0

--

PROactive

Microalbuminuria (%)

14.3

--

PROactive

Neuropathy (%)

25.6

--

PROactive

  1. HbA1c = glycosylated haemoglobin; BMI = body mass index; HDL-C = high density lipoprotein cholesterol; LDL-C = low density lipoprotein cholesterol; ACS = acute coronary syndrome; CABG = coronary artery bypass graft; PCI = percutaneous coronary intervention; MI = myocardial infarction